Share this article

An observational pilot study to collect safety and efficacy data on wound care using whole blood clot technology on hard-to-heal wounds

Dino Rech, Febe Bruwer, Georges Balenda, Liezl Naude, Magda Mulder, Maxim Gurevich, Moreno Matityahu, Patricia Idensohn, Ruhama Fridman, Yael Izakson
18 May 2021

This multi-centre observational pilot study explored the use of whole blood clot (WBC) therapy on hard-to-heal wounds where the phases of wound healing have been interrupted or stalled. Primary data from 29 patients were gathered from 10 pilot sites in South Africa and Israel. Prior to the application of WBC as an advanced technology, several other advanced wound care technologies, devices and wound care products were used in 48% of patients for more than 12 months, without achieving wound closure. An average of 65% reduction in wound size was achieved in 4 weeks in this pilot study, illustrating safety and efficacy for WBC application in hard-to-heal wounds.

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.